- Home
- SGML vs BCRX Comparison
SGML vs BCRX Comparison
Compare SGML & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGML
- BCRX
- Stock Information
- Founded
- SGML 2011
- BCRX 1986
- Country
- SGML Brazil
- BCRX United States
- Employees
- SGML N/A
- BCRX N/A
- Industry
- SGML Industrial Machinery/Components
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SGML Industrials
- BCRX Health Care
- Exchange
- SGML Nasdaq
- BCRX Nasdaq
- Market Cap
- SGML 518.6M
- BCRX 1.9B
- IPO Year
- SGML N/A
- BCRX 1994
- Fundamental
- Price
- SGML $5.44
- BCRX $8.76
- Analyst Decision
- SGML Strong Buy
- BCRX Strong Buy
- Analyst Count
- SGML 2
- BCRX 10
- Target Price
- SGML $18.00
- BCRX $16.70
- AVG Volume (30 Days)
- SGML 2.1M
- BCRX 3.4M
- Earning Date
- SGML 08-14-2025
- BCRX 08-04-2025
- Dividend Yield
- SGML N/A
- BCRX N/A
- EPS Growth
- SGML N/A
- BCRX N/A
- EPS
- SGML N/A
- BCRX N/A
- Revenue
- SGML $152,515,393.00
- BCRX $503,485,000.00
- Revenue This Year
- SGML $43.73
- BCRX $39.04
- Revenue Next Year
- SGML $130.53
- BCRX $13.26
- P/E Ratio
- SGML N/A
- BCRX N/A
- Revenue Growth
- SGML 0.36
- BCRX 41.67
- 52 Week Low
- SGML $4.25
- BCRX $6.02
- 52 Week High
- SGML $15.56
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- SGML 52.92
- BCRX 32.20
- Support Level
- SGML $4.94
- BCRX $8.71
- Resistance Level
- SGML $5.95
- BCRX $9.23
- Average True Range (ATR)
- SGML 0.39
- BCRX 0.31
- MACD
- SGML 0.18
- BCRX -0.08
- Stochastic Oscillator
- SGML 70.00
- BCRX 5.07
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.